News
Targeted Treatment of Children and Adolescents with Severe AD – Case Studies
The results of therapy with dupilumab in children and adolescents with severe forms of atopic dermatitis (AD) are very good even after a short period, not only from a health perspective but also in terms of the social aspect of the disease and the quality of life of patients. This is illustrated by the following two case studies – an 8-year-old girl and a 17-year-old boy – from the Center for Biological Treatment at the Dermatovenerology Clinic of the 2nd Faculty of Medicine, Charles University, and Bulovka University Hospital.
Carpal Tunnel Syndrome as a Warning Sign of Cardiomyopathy Caused by Transthyretin Amyloidosis
Recent study results suggest that transthyretin amyloidosis is a more common cause of heart failure…
INFOGRAPHIC: Diagnostic Algorithm for Cardiac Amyloidosis
What examinations are needed when cardiac amyloidosis is suspected? Which tests can distinguish…
Current Position of Venetoclax in the Treatment of AML − Hope for a Better Prognosis?
The treatment of acute myeloid leukemia (AML) remained stagnant for a long time, with many new…
Venetostart – The First Comprehensive Mobile Application with Practical Information for Venetoclax Treatment
Abbvie has developed the comprehensive mobile application Venetostart with practical information…
INFOGRAPHIC: Which treatment to choose in the 1st line for a patient with type 2 diabetes?
Diabetes mellitus is a complex chronic disease that requires continuous treatment and a strategy to...
Is exposure to mite allergens in breast milk or house dust a risk factor for asthma and allergies in childhood?
Exposure to mite allergens occurs early in life from both breast milk and house dust (especially bedding)....
Sonicare Technology as a Modern Means for Good Oral Hygiene
Sonicare technology was developed and introduced to the market by Philips 30 years ago. Since then,…
Technology as an Aid in Home Oral Care
Good oral hygiene is a prerequisite for good health, both in the mouth area and in terms of overall...
Romiplostim in Newly Diagnosed or Persistent ITP
Thrombopoietin receptor agonists (TPO-RA) are now recommended for patients with newly diagnosed…
Popular this week
- Vaccination Against Hepatitis A Has Been Most Neglected Among People With Liver Disease
- How Is Adolescent Self-Harm Related to Addiction?
- AI Searches for New Antibiotics in Animal Venoms
- What Are the Links Between Gambling, Depression, and Feelings of Escape During Play?
- AI-Powered Phishing: A Growing Threat to Healthcare